Physician

Alan Merrill Dietzek, M.D.

According to 2025 Medicare claims, Alan Dietzek, M.D. (NPI: 1134160435) practices vascular surgery in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 07733-1514. Dietzek is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Dietzek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 798 traditional Medicare patients, billed 2,177 HCPCS/CPT codes, and received $107,583 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 80 prescription claims across 23 beneficiaries totaling $9,673 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 39 records totaling $5,266. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $299,968 to $107,583. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,721 and ending at $9,673. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,690	3,200	$299,968
2016	1,949	3,395	$286,931
2017	1,720	2,894	$240,646
2018	1,429	2,330	$198,593
2019	1,571	2,693	$231,189
2020	1,252	2,270	$212,143
2021	1,469	2,398	$188,190
2022	1,269	2,098	$174,881
2023	840	1,373	$133,189
2024	798	2,177	$107,583

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	36	$2,721
2016	23	36	$3,681
2017	31	64	$9,102
2018	26	58	$4,564
2019	28	74	$12,183
2020	33	76	$9,516
2021	26	58	$2,914
2022	28	60	$8,140
2023	24	67	$11,113
2024	23	80	$9,673

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	112	$106
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	103	143	$73
93880	Ultrasound of both sides of head and neck blood flow	93	93	$28
93970	Ultrasound study of arm or leg veins with compression and maneuvers	228	234	$27
93971	Ultrasound study of one arm or leg veins with compression and maneuvers	141	154	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	13	390	$7,234
Cilostazol	Cilostazol	38	2,460	$1,005
Clopidogrel	Clopidogrel Bisulfate	23	1,050	$229

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$3,266	Bard Peripheral Vascular, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$2,000	Penumbra, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$100,001	Vantis Vascular, Inc.

Explore More Providers

FAQ

What Medicare data is available for Alan Merrill Dietzek, M.D.?

Tedicare shows public-source Medicare data for Alan Merrill Dietzek, M.D. (NPI 1134160435), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Merrill Dietzek, M.D. have ACO affiliation data?

Alan Merrill Dietzek, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Alan Merrill Dietzek, M.D.?

Alan Merrill Dietzek, M.D. is linked to HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (billing NPI 1215989249) in the available physician profile data.

Does Alan Merrill Dietzek, M.D. have Open Payments data?

Alan Merrill Dietzek, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.